AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-98
Results: 1-25/98
SAMPLE DILUTION - A METHODOLOGICAL PITFALL IN THE MEASUREMENT OF TISSUE BUT NOT SERUM ACE-ACTIVITY
Authors: KOITER J NAVIS G DEJONG PE VANGILST WH DEZEEUW D
Citation: J. Koiter et al., SAMPLE DILUTION - A METHODOLOGICAL PITFALL IN THE MEASUREMENT OF TISSUE BUT NOT SERUM ACE-ACTIVITY, Journal of pharmacological and toxicological methods, 39(1), 1998, pp. 45-49
ANGIOTENSIN-II TYPE-1 RECEPTOR POLYMORPHISM IS ASSOCIATED WITH AN INCREASED VASOREACTIVITY TO ANGIOTENSIN-II IN HUMAN ARTERIES
Authors: VANGEEL PP VOORS AA OOSTERGA M PINTO YM BUIKEMA H KINGMA JH CRIJNS HJGM VANGILST WH
Citation: Pp. Vangeel et al., ANGIOTENSIN-II TYPE-1 RECEPTOR POLYMORPHISM IS ASSOCIATED WITH AN INCREASED VASOREACTIVITY TO ANGIOTENSIN-II IN HUMAN ARTERIES, Journal of the American College of Cardiology, 31(2), 1998, pp. 26-26
FUNCTIONAL-EFFECTS OF ACE-INHIBITORS ON ANGIOTENSIN-I CONVERSION IN HUMAN VASCULATURE
Authors: OOSTERGA M VOORS AA BUIKEMA H PINTO YM HABER HE MORSHUIS W KINGMA JH EBELS T CRIJNS HJGM VANGILST WH
Citation: M. Oosterga et al., FUNCTIONAL-EFFECTS OF ACE-INHIBITORS ON ANGIOTENSIN-I CONVERSION IN HUMAN VASCULATURE, Journal of the American College of Cardiology, 31(2), 1998, pp. 239-240
THE ANGIOTENSIN-CONVERTING ENZYME DD GENOTYPE IS ASSOCIATED WITH A DECREASED RESPONSE TO ANGIOTENSIN-II IN HUMAN ARTERIES
Authors: VANGEEL PP VOORS AA OOSTERGA M PINTO YM BUIKEMA H VANBUITEN A CRIJNS HJGM KINGMA JH VANGILST WH
Citation: Pp. Vangeel et al., THE ANGIOTENSIN-CONVERTING ENZYME DD GENOTYPE IS ASSOCIATED WITH A DECREASED RESPONSE TO ANGIOTENSIN-II IN HUMAN ARTERIES, Journal of the American College of Cardiology, 31(2), 1998, pp. 350-350
INHIBITION OF GROWTH-FACTORS IN MYOCARDIAL INFARCTED RATS BLUNTS LEFT-VENTRICULAR DYSFUNCTION
Authors: PHILIPP TP PINTO SJ VANGILST WH BUIKEMA H PAUL M PINTO YM
Citation: Tp. Philipp et al., INHIBITION OF GROWTH-FACTORS IN MYOCARDIAL INFARCTED RATS BLUNTS LEFT-VENTRICULAR DYSFUNCTION, Journal of hypertension, 16, 1998, pp. 3905-3905
IS THE A(1166)C POLYMORPHISM OF THE ANGIOTENSIN-II TYPE-1 RECEPTOR INVOLVED IN CARDIOVASCULAR-DISEASE
Authors: VANGEEL PP PINTO YM BUIKEMA H VANGILST WH
Citation: Pp. Vangeel et al., IS THE A(1166)C POLYMORPHISM OF THE ANGIOTENSIN-II TYPE-1 RECEPTOR INVOLVED IN CARDIOVASCULAR-DISEASE, European heart journal, 19, 1998, pp. 13-17
LONG-TERM FOLLOW-UP AFTER EARLY INTERVENTION WITH INTRAVENOUS DILTIAZEM OR INTRAVENOUS NITROGLYCERIN FOR UNSTABLE ANGINA-PECTORIS
Authors: GOBEL EJAM VANGILST WH DEKAM PJ TERNAPEL MGJ MOLHOEK GP LIE KI
Citation: Ejam. Gobel et al., LONG-TERM FOLLOW-UP AFTER EARLY INTERVENTION WITH INTRAVENOUS DILTIAZEM OR INTRAVENOUS NITROGLYCERIN FOR UNSTABLE ANGINA-PECTORIS, European heart journal, 19(8), 1998, pp. 1208-1213
LEFT-VENTRICULAR DILATATION AFTER MYOCARDIAL-INFARCTION - ACE-INHIBITORS, BETA-BLOCKERS OR BOTH
Authors: ANTHONIO RL VANVELDHUISEN DJ VANGILST WH
Citation: Rl. Anthonio et al., LEFT-VENTRICULAR DILATATION AFTER MYOCARDIAL-INFARCTION - ACE-INHIBITORS, BETA-BLOCKERS OR BOTH, Journal of cardiovascular pharmacology, 32, 1998, pp. 1-8
CURRENT INSIGHTS AND NEW TREATMENT OPTIONS IN HEART-FAILURE
Authors: VANVELDHUISEN DJ VANGILST WH FRANCIS FS
Citation: Dj. Vanveldhuisen et al., CURRENT INSIGHTS AND NEW TREATMENT OPTIONS IN HEART-FAILURE, Journal of cardiovascular pharmacology, 32, 1998, pp. 5-6
CHANGES IN CANNABINOID RECEPTOR MESSENGER-RNA LEVELS IN FAILING HUMANDILATED CARDIOMYOPATHY
Authors: NELEMANS SA BRUNDEL BJJM HENNING RH BOHM M VANGILST WH
Citation: Sa. Nelemans et al., CHANGES IN CANNABINOID RECEPTOR MESSENGER-RNA LEVELS IN FAILING HUMANDILATED CARDIOMYOPATHY, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 3694-3694
DO WE KNOW THE LONG-TERM EFFECTS OF STENT IMPLANTATION ON CORONARY ENDOTHELIAL FUNCTION
Authors: MONNINK SHJ VANBOVEN AJ PEELS HOJ TIO RA DENHEIJER P VANDERGIESSEN WJ VANGILST WH CRIJNS HJGM
Citation: Shj. Monnink et al., DO WE KNOW THE LONG-TERM EFFECTS OF STENT IMPLANTATION ON CORONARY ENDOTHELIAL FUNCTION, Circulation, 98(17), 1998, pp. 977-977
THE ANGIOTENSIN-II TYPE-1 RECEPTOR POLYMORPHISM IS ASSOCIATED WITH DIFFERENTIAL ENDOTHELIUM-DEPENDENT VASODILATION IN HUMAN ARTERIES
Authors: VANGEEL PP PINTO YM BUIKEMA H OOSTERGA M VOORS AA VANGILST WH
Citation: Pp. Vangeel et al., THE ANGIOTENSIN-II TYPE-1 RECEPTOR POLYMORPHISM IS ASSOCIATED WITH DIFFERENTIAL ENDOTHELIUM-DEPENDENT VASODILATION IN HUMAN ARTERIES, Circulation, 98(17), 1998, pp. 1263-1263
EFFECTS OF CAPTOPRIL ON EARLY AND LATE ARRHYTHMIC EVENTS IN PATIENTS TREATED WITH THROMBOLYTIC THERAPY FOR A FIRST ANTERIOR MYOCARDIAL-INFARCTION - THE CONTINUING STORY OF CATS
Authors: DAMBRINK JHE KINGMA JH VANGILST WH
Citation: Jhe. Dambrink et al., EFFECTS OF CAPTOPRIL ON EARLY AND LATE ARRHYTHMIC EVENTS IN PATIENTS TREATED WITH THROMBOLYTIC THERAPY FOR A FIRST ANTERIOR MYOCARDIAL-INFARCTION - THE CONTINUING STORY OF CATS, Circulation, 98(17), 1998, pp. 1457-1457
NEUROHORMONAL PROFILE OF PATIENTS WITH MODERATE TO SEVERE CHRONIC HEART-FAILURE TREATED CHRONICALLY WITH BETA-BLOCKERS AS ADJUNCT TO ACE-INHIBITORS
Authors: TEISMAN ACH VANVELDHULSEN DJ DEKARN PJ BOOMSMA F TJEERDSMA G PINTO YM DEZEEUW D VANGILST WH
Citation: Ach. Teisman et al., NEUROHORMONAL PROFILE OF PATIENTS WITH MODERATE TO SEVERE CHRONIC HEART-FAILURE TREATED CHRONICALLY WITH BETA-BLOCKERS AS ADJUNCT TO ACE-INHIBITORS, Circulation, 98(17), 1998, pp. 1915-1915
BENEFICIAL-EFFECTS OF QUINAPRIL ON ISCHEMIA IN CORONARY-BYPASS SURGERY PATIENTS - ONE-YEAR CLINICAL FOLLOW-UP OF THE QUO-VADIS STUDY
Authors: OOSTERGA M VOORS AA VEEGER NJGM PINTO YM KINGMA JH CRIJNS HJGM VANGILST WH
Citation: M. Oosterga et al., BENEFICIAL-EFFECTS OF QUINAPRIL ON ISCHEMIA IN CORONARY-BYPASS SURGERY PATIENTS - ONE-YEAR CLINICAL FOLLOW-UP OF THE QUO-VADIS STUDY, Circulation, 98(17), 1998, pp. 3343-3343
BETA-ADRENERGIC SIGNAL-TRANSDUCTION FOLLOWING CARVEDILOL TREATMENT INHYPERTENSIVE CARDIAC-HYPERTROPHY
Authors: BOHM M ETTELBRUCK S FLESCH M VANGILST WH KNORR A MAACK C PINTO YM PAUL M TEISMAN ACH ZOLK O
Citation: M. Bohm et al., BETA-ADRENERGIC SIGNAL-TRANSDUCTION FOLLOWING CARVEDILOL TREATMENT INHYPERTENSIVE CARDIAC-HYPERTROPHY, Cardiovascular Research, 40(1), 1998, pp. 146-155
DUAL PATHWAY FOR ANGIOTENSIN-II FORMATION IN HUMAN INTERNAL MAMMARY ARTERIES
Authors: VOORS AA PINTO YM BUIKEMA H URATA H OOSTERGA M ROOS G GRANDJEAN JG GANTEN D VANGILST WH
Citation: Aa. Voors et al., DUAL PATHWAY FOR ANGIOTENSIN-II FORMATION IN HUMAN INTERNAL MAMMARY ARTERIES, British Journal of Pharmacology, 125(5), 1998, pp. 1028-1032
EFFECTS OF QUINAPRIL, LOSARTAN AND HYDRALAZINE ON CARDIAC-HYPERTROPHYAND BETA-ADRENERGIC NEUROEFFECTOR MECHANISMS IN TRANSGENIC (MREN2)27 RATS
Authors: ZOLK O FLESCH M SCHNABEL P TEISMAN AC PINTO YM VANGILST WH PAUL M BOHM M
Citation: O. Zolk et al., EFFECTS OF QUINAPRIL, LOSARTAN AND HYDRALAZINE ON CARDIAC-HYPERTROPHYAND BETA-ADRENERGIC NEUROEFFECTOR MECHANISMS IN TRANSGENIC (MREN2)27 RATS, British Journal of Pharmacology, 123(3), 1998, pp. 405-412
EFFECTS OF ASPIRIN ON ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND LEFT-VENTRICULAR DILATION ONE-YEAR AFTER ACUTE MYOCARDIAL-INFARCTION
Authors: OOSTERGA M ANTHONIO RL DEKAM PJ KINGMA JH CRIJNS HJGM VANGILST WH
Citation: M. Oosterga et al., EFFECTS OF ASPIRIN ON ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND LEFT-VENTRICULAR DILATION ONE-YEAR AFTER ACUTE MYOCARDIAL-INFARCTION, The American journal of cardiology, 81(10), 1998, pp. 1178-1181
CARDIOVASCULAR END-ORGAN DAMAGE IN REN-2 TRANSGENIC RATS COMPARED TO SPONTANEOUSLY HYPERTENSIVE RATS
Authors: PINTO YM BUIKEMA H VANGILST WH SCHOLTENS E VANGEEL PP DEGRAEFF PA WAGNER J PAUL M
Citation: Ym. Pinto et al., CARDIOVASCULAR END-ORGAN DAMAGE IN REN-2 TRANSGENIC RATS COMPARED TO SPONTANEOUSLY HYPERTENSIVE RATS, Journal of molecular medicine, 75(5), 1997, pp. 371-377
THE RENIN-ANGIOTENSIN SYSTEM AND VASCULAR FUNCTION - THE ROLE OF ANGIOTENSIN-II, ANGIOTENSIN-CONVERTING ENZYME, AND ALTERNATIVE CONVERSION OF ANGIOTENSIN-I
Authors: ROKS A BUIKEMA H PINTO YM VANGILST WH
Citation: A. Roks et al., THE RENIN-ANGIOTENSIN SYSTEM AND VASCULAR FUNCTION - THE ROLE OF ANGIOTENSIN-II, ANGIOTENSIN-CONVERTING ENZYME, AND ALTERNATIVE CONVERSION OF ANGIOTENSIN-I, Heart and vessels, 1997, pp. 119-124
LONG-TERM ANTIISCHEMIC EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN PATIENTS AFTER MYOCARDIAL-INFARCTION
Authors: VANDENHEUVEL AFM VANGILST WH VANVELDHUISEN DJ DEVRIES RJM DUNSELMAN PHJM KINGMA JH
Citation: Afm. Vandenheuvel et al., LONG-TERM ANTIISCHEMIC EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN PATIENTS AFTER MYOCARDIAL-INFARCTION, Journal of the American College of Cardiology, 30(2), 1997, pp. 400-405
WITHDRAWAL OF CAPTOPRIL, AFTER LONG-TERM TREATMENT, INCREASES ISCHEMIC EVENTS IN POSTMYOCARDIAL INFARCTION PATIENTS
Authors: VANDENHEUVEL AFM VANGILST WH VANVELDHUISEN DJ DEVRIES RJM DUNSELMAN PHJM KINGMA JH
Citation: Afm. Vandenheuvel et al., WITHDRAWAL OF CAPTOPRIL, AFTER LONG-TERM TREATMENT, INCREASES ISCHEMIC EVENTS IN POSTMYOCARDIAL INFARCTION PATIENTS, Journal of the American College of Cardiology, 29(2), 1997, pp. 7873-7873
DECREASED LEVELS OF I-KACH MESSENGER-RNA IN PATIENTS WITH CHRONIC ATRIAL-FIBRILLATION BUT NO CHANGES IN THE SARCOPLASMIC-RETICULUM CALCIUM-ATPASE AND PHOSPHOLAMBAN
Authors: BRUNDEL BJ VANGELDER IC HENNING RH DEELMAN LE TUINENBURG AE VANGILST WH CRIJNS HJ
Citation: Bj. Brundel et al., DECREASED LEVELS OF I-KACH MESSENGER-RNA IN PATIENTS WITH CHRONIC ATRIAL-FIBRILLATION BUT NO CHANGES IN THE SARCOPLASMIC-RETICULUM CALCIUM-ATPASE AND PHOSPHOLAMBAN, Journal of the American College of Cardiology, 29(2), 1997, pp. 41142-41142
TOTAL SERUM-CHOLESTEROL IS THE BEST PREDICTOR FOR ENDOTHELIAL DYSFUNCTION IN INTERNAL MAMMARY ARTERIES OF CORONARY-BYPASS PATIENTS
Authors: VOORS AA OOSTERGA M BUIKEMA H PINTO YM GRANDJEAN JG MORSHUIS WJ KINGMA JH VANGILST WH
Citation: Aa. Voors et al., TOTAL SERUM-CHOLESTEROL IS THE BEST PREDICTOR FOR ENDOTHELIAL DYSFUNCTION IN INTERNAL MAMMARY ARTERIES OF CORONARY-BYPASS PATIENTS, Journal of the American College of Cardiology, 29(2), 1997, pp. 92194-92194
Risultati: 1-25 | 26-50 | 51-75 | 76-98